insights_auto
Why is ORX down 26.90%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 1.00
arrow_downward
-26.90%(-0.37) 1D
Nov 9, 3:45:59 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 1.03
High
SEKÂ 1.25
Low
SEKÂ 0.99
Mkt. cap
35.08M
Avg. vol.
337.59K
Volume
1.25M
P/E ratio
0.05
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 0.99
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 1.03
High
SEKÂ 1.25
Low
SEKÂ 0.99
Mkt. cap
35.08M
Avg. vol.
337.59K
Volume
1.25M
P/E ratio
0.05
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 0.99
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Quartz
·
7 minutes ago
Dow jumps more than 600 points as oil slides and Nvidia stock falls
FXStreet
·
1 hour ago
The S&P 500 is counting on support from the Fed
24/7 Wall St.
·
1 hour ago
2 Safe S&P 500 Tech Dividend Stocks Boomers Can Buy and Hold Forever
Yahoo Finance
·
3 hours ago
What iShares Core S&P 500 ETF (IVV) Bought: Apple Leads on Nov. 5
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com